Search results
Results From The WOW.Com Content Network
Alcon offices in Johns Creek, Georgia. Alcon Inc. (‹See Tfd› German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
This is a list of notable Singaporean exchange-traded funds, or ETFs . ABF Singapore Bond Index Fund. CIMB FTSE ASEAN40 ETF. CIMB S&P Ethical Asia Pacific Dividend ETF. db x-trackers CSI300 UCITS ETF. db x-trackers DB Commodity Booster Bloomberg UCITS ETF. db x-trackers DB Commodity Booster Light Energy Benchmark UCITS ETF.
It is also the second-largest pharmaceutical company by market cap in 2019. [127] Alcon: At the time Novartis bought Alcon, they had annual sales of $6.5 billion and a net income of $2 billion. [128] In April 2019, Novartis completed the spin-off of Alcon as a separate commercial entity. [73]
A-Smart Holdings Ltd. Singapore. SG1CF3000008. 28 June 1999. A-Sonic Aerospace Limited. Singapore. SG1CH8000009. 17 September 2003. ABF Singapore Bond Index Fund.
On July 14, 2020, Wedgewood Partners released its Q2 2020 Investor Letter, a copy of which you can download here. The Fund returned 27.13% for the second quarter of 2020. Meanwhile, the benchmark ...
The Straits Times Index (abbreviation: STI) is a capitalisation-weighted measurement stock market index that is regarded as the benchmark index for the stock market in Singapore. It tracks the performance of the top 30 companies that are listed on the Singapore Exchange (SGX). The STI is jointly calculated by the SGX, the SPH Media Trust and ...
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products.
Gilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.